Johnson et al. showed that HLA-DR positivity in tumor cells is related to a therapeutic response, as well as the amount of tumor infiltrated CD4- and CD8-positive T cells in anti-PD-1-treated patients with melanoma [41]. The gene discussed is CD8A; the disease is melanoma.